| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 45.3644 | 29 |
| GSM780708 | Untreated after 4 days (C2_1) | 48.22 | 42 |
| GSM780709 | Untreated after 4 days (C3_1) | 42.784 | 16 |
| GSM780719 | Untreated after 4 days (C1_2) | 42.613 | 16 |
| GSM780720 | Untreated after 4 days (C2_2) | 49.6448 | 47 |
| GSM780721 | Untreated after 4 days (C3_2) | 43.0139 | 17 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 44.7152 | 26 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 41.6469 | 12 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 44.3016 | 24 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.7833 | 44 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 49.2649 | 46 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 41.45 | 11 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 43.0857 | 18 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 41.0707 | 10 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.4433 | 39 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 52.9236 | 56 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 50.5881 | 50 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.5315 | 47 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 46.7286 | 35 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.651 | 35 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 46.5344 | 35 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.5155 | 34 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.5993 | 30 |